Ad Hoc Announcement Pursuant to Art. 53 LR
Geneva, Switzerland, March 31, 2022 - Addex Therapeutics (SIX:ADXN and Nasdaq:ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that its Annual General Meeting will take place on Monday May 9, 2022 at 11:00am CEST at the Campus Biotech, Chemin des Mines 9, 1202 Geneva.
Read more at globenewswire.com